Cite
HARVARD Citation
Matikas, A. et al. (2017). Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer. Expert review of anticancer therapy. 17 (4), pp. 319-326. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Matikas, A. et al. (2017). Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer. Expert review of anticancer therapy. 17 (4), pp. 319-326. [Online].